248 related articles for article (PubMed ID: 34857730)
1. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
[TBL] [Abstract][Full Text] [Related]
3. [80-year-old patient with dyspnoea, back ache and peripheral oedema. Plasma cell leukemia in multiple myeloma].
Austein T; Demme B
Dtsch Med Wochenschr; 2010 Nov; 135(44):2187-8. PubMed ID: 20979004
[No Abstract] [Full Text] [Related]
4. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
Fernández de Larrea C; Kyle RA; Durie BG; Ludwig H; Usmani S; Vesole DH; Hajek R; San Miguel JF; Sezer O; Sonneveld P; Kumar SK; Mahindra A; Comenzo R; Palumbo A; Mazumber A; Anderson KC; Richardson PG; Badros AZ; Caers J; Cavo M; LeLeu X; Dimopoulos MA; Chim CS; Schots R; Noeul A; Fantl D; Mellqvist UH; Landgren O; Chanan-Khan A; Moreau P; Fonseca R; Merlini G; Lahuerta JJ; Bladé J; Orlowski RZ; Shah JJ;
Leukemia; 2013 Apr; 27(4):780-91. PubMed ID: 23288300
[TBL] [Abstract][Full Text] [Related]
5. Oligosecretory Primary Plasma Cell Leukemia with Atypical Morphological Abnormality.
Toriyama E; Imaizumi Y; Tsuruda K; Itonaga H; Sato S; Ando K; Sawayama Y; Hasegawa H; Hata T; Niino D; Yanagihara K; Miyazaki Y
Intern Med; 2019 Aug; 58(15):2213-2217. PubMed ID: 30996175
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
An G; Qin X; Acharya C; Xu Y; Deng S; Shi L; Zang M; Sui W; Yi S; Li Z; Hao M; Feng X; Jin F; Zou D; Qi J; Zhao Y; Tai YT; Wang J; Qiu L
Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
Li F; Gao YJ; Li SS; Xi YY; Yang XW; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1771-1779. PubMed ID: 38071059
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract][Full Text] [Related]
10. Plasma cell leukemia: from biology to treatment.
Jelinek T; Kryukov F; Rihova L; Hajek R
Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
[TBL] [Abstract][Full Text] [Related]
11. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Jelinek T; Bezdekova R; Zihala D; Sevcikova T; Anilkumar Sithara A; Pospisilova L; Sevcikova S; Polackova P; Stork M; Knechtova Z; Venglar O; Kapustova V; Popkova T; Muronova L; Chyra Z; Hrdinka M; Simicek M; Garcés JJ; Puig N; Cedena MT; Jurczyszyn A; Castillo JJ; Penka M; Radocha J; Mateos MV; San-Miguel JF; Paiva B; Pour L; Rihova L; Hajek R
J Clin Oncol; 2023 Mar; 41(7):1383-1392. PubMed ID: 36315921
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
Guan J; Ma J; Chen B
Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
[TBL] [Abstract][Full Text] [Related]
13. [Primary plasma cell leukemia: about 3 cases].
Miloudi M; Messaoudi N
Pan Afr Med J; 2016; 24():167. PubMed ID: 27795764
[TBL] [Abstract][Full Text] [Related]
14. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK
Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254
[TBL] [Abstract][Full Text] [Related]
15. A systematic study comparing aspirate versus trephine for quantifying plasma cell infiltration in newly-diagnosed myeloma.
Gabriel J; McGovern A; Robinson S; Wright D; Chevassut T
Br J Haematol; 2016 Sep; 174(5):818-20. PubMed ID: 26492094
[No Abstract] [Full Text] [Related]
16. Plasma cell leukemia.
Albarracin F; Fonseca R
Blood Rev; 2011 May; 25(3):107-12. PubMed ID: 21295388
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell leukemia masquerading as ALL-L3--a case report.
Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R
Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia.
Tabchi S; Nair R; Kunacheewa C; Patel KK; Lee HC; Thomas SK; Amini B; Ahmed S; Mehta RS; Bashir Q; Qazilbash MH; Weber DM; Orlowski RZ; Alexanian R; Feng L; Manasanch EE
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):560-569. PubMed ID: 31201134
[TBL] [Abstract][Full Text] [Related]
19. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
Gangadhar P; Ahmed Z; Pai MR; Sandhya I
Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
[TBL] [Abstract][Full Text] [Related]
20. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
Cytometry B Clin Cytom; 2015 Jan; 88(1):69-73. PubMed ID: 24715427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
